Prof Ana Carneiro speaks to ecancer in an online interview for the virtual ESMO 2020 meeting about disparities in access to oncology clinical trials in Europe between 2009-2019.
Prof Carneiro explains the motivations for the study and how it was conducted. She reports that, as the researchers anticipated, they observed that the number of oncology clinical trials varies greatly across Europe.
Prof Carneiro explains that this is concerning as it suggests potential asymetries in patients' access to clinical trials. However, she says that by comparing countries and regions in this way there is opportunity for improvement.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.